(79 days)
Not Found
No
The document mentions "image processing" but does not contain any terms or descriptions indicative of AI or ML technologies like neural networks, algorithms for automated analysis, or learning from data.
No
The device is described as an imaging system intended for visualization and assessment, not for direct treatment or therapy. Its purpose is to provide visual information to aid surgical procedures, not to perform a therapeutic action itself.
Yes
The device aids in the visual assessment of vessels, blood flow, tissue perfusion, and biliary ducts, and is used for intraoperative fluorescence imaging and visualization of the lymphatic system. These are all activities that help in identifying or classifying diseases or conditions, which falls under the definition of a diagnostic device.
No
The device description explicitly lists multiple hardware components, including endoscopes, telescopes, camera head, light source, footswitch, fiber light cables, and a CCU. While it mentions image processing, it is part of a larger hardware system.
Based on the provided information, the KARL STORZ ICG Imaging System is not an In Vitro Diagnostic (IVD).
Here's why:
- IVDs analyze samples taken from the human body. The device description and intended use clearly state that this system is used for in vivo imaging (imaging within the living body) during surgical procedures. It visualizes structures like vessels, bile ducts, lymphatic systems, and surgical fields directly within the patient.
- The system uses imaging modalities (VIS and NIR fluorescence) to visualize structures in situ. It does not process or analyze biological samples like blood, urine, or tissue biopsies in a laboratory setting.
- The device description focuses on the imaging hardware and its function in providing real-time visualization. It doesn't mention any components or processes related to the analysis of biological samples.
The device is a surgical imaging system that utilizes fluorescence to enhance visualization during procedures, which is distinct from the function of an IVD.
N/A
Intended Use / Indications for Use
The KARL STORZ ICG Imaging System is intended to provide real-time visible (VIS) and near-infrared (NIR) fluorescence imaging.
Upon intravenous administration and use of ICG consistent with its approved label, the KARL STORZ Endoscopic ICG System enables surgeons to perform minimally invasive surgery using standard endoscopic visible light as well as visual assessment of vessels, blood flow and related tissue perfusion, and at least one of the major extra-hepatic bile ducts (cystic duct, common bile duct and common hepatic duct), using near infrared imaging of biliary ducts with the KARL STORZ Endoscopic ICG System is intended for use with standard of care white light and, when indicated, intraoperative cholangiography. The device is not intended for standalone use for biliary duct visualization.
Additionally, the KARL STORZ Endoscopic ICG System enables surgeon to perform minimally invasive cranial neurosurgery in adults and pediatrics and endonasal skull base surgery in adults and pediatrics > 6 years of age using standard endoscopic visible light as well as visual assessment of vessels, blood flow and related tissue perfusion using near infrared imaging.
The KARL STORZ VITOM II ICG System is intended for capturing fluorescent mages for the visual assessment of blood flow, as an adjunctive method for the evaluation of tissue perfusion, and related tissue-transfer circulation in tissue and free flaps used in plastic, micro- and reconstructive surgical procedures. The VITOM II ICG System is intended to provide a magnified view of the surgical field in standard white light.
Upon interstitial administration and use of ICG consistent with its approved label, the KARL STORZ Endoscopic ICG System is used to perform intraoperative fluorescence imaging and visualization of the lymphatic system, including lymphatic vessels and lymph nodes.
Product codes
OWN, GWG
Device Description
The subject device, KARL STORZ ICG Imaging System includes the following components: 4mm, 5mm & 10mm HOPKINS ICG/NIR Endoscopes VITOM II ICG Telescope Image1 S Rubina Camera head Power LED Rubina light source, footswitch Fiber Light Cables Image1 S CCU.
The expanded indication for visualization of the lymphatic vessel is only to the Endoscopic ICG system that includes the 4mm, 5mm & 10mm HOPKINS ICG/NIR Endoscopes.
The addition of the reprocessing modalities is to the 4mm, 5mm & 10mm HOPKINS ICG/NIR Endoscopes and the VITOM II ICG/NIR telescope.
The endoscopes/telescope are intended to be connected to the optical coupler of the camera head, which connects to the CCU for image processing, as well as to the light source via compatible light cable as the source of illumination to allow visualization of internal anatomy. The users can switch between WLi (standard white light) mode, for visualization of the endoscopic and microscopic procedures and NIR (Near Infrared) mode to detect ICG presence.
The KARL STORZ ICG Imaging System can be used with any medical grade monitor with a DVI-D or 12G/3G-SDI input.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Visible (VIS) light, Near-infrared (NIR) fluorescence imaging
Anatomical Site
Bile ducts (cystic duct, common bile duct and common hepatic duct), Cranial, Endonasal skull base, Tissue and free flaps (plastic, micro-, and reconstructive surgical procedures), Lymphatic system (lymphatic vessels and lymph nodes).
Indicated Patient Age Range
Adults and pediatrics for cranial neurosurgery. Adults and pediatrics > 6 years of age for endonasal skull base surgery. Not specified for other indications.
Intended User / Care Setting
Surgeons (minimally invasive surgery, cranial neurosurgery, endonasal skull base surgery, plastic, micro- and reconstructive surgical procedures). The device is for Prescription Use.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-Clinical Performance Data: Non-clinical bench testing was sufficient to establish substantial equivalence of the expanded indications.
The KARL STORZ ICG Imaging System follows the FDA recognized consensus standards and is tested according to the following standards and FDA Guidance: Electrical Safety and EMC (IEC 60601-1, IEC 60601-1-2, IEC 60601-2-18), ISO Endoscopic Standards (ISO 8600-1, ISO 8600-3, ISO 8600-4, ISO 8600-5, ISO 8600-6).
The expansion of the indication of the subject device does not change the biocompatibility, electrical safety, electromagnetic compatibility, or software validations and remain identical since last clearance (K201399).
Sterilization validations of the additional modalities were conducted for the HOPKINS ICG/NIR Endoscopes and the VITOM II ICG/NIR telescopes.
The performance of the subject device, KARL STORZ ICG Imaging System for VIS imaging has been verified and previously cleared in K201399 as the expanded indication for fluorescence imaging and visualization of the lymphatic system does not affect its performance in white light mode.
The photobiological safety of the subject device per the FDA recognized standard IEC 62471 has been verified and previously cleared in K201399.
The performance of the subject device for NIR imaging has been demonstrated by comparing to the primary predicate device, PINPOINT Endoscopic Fluorescence Imaging System to support the expanded indication for fluorescent imaging and visualization of the lymphatic system.
Clinical Performance Data: Clinical testing was not required to demonstrate the substantial equivalence to the predicate devices. Non-clinical bench testing was sufficient to establish substantial equivalence of the expanded indications.
Conclusion: The conclusions drawn from the cleaning and sterilization data (Section 17), Software Data (Section 19), Electrical Safety and EMC data (Section 20), as well as the Bench Top Performance Data (Section 21) demonstrated that the subject device is as safe and as effective as the primary and secondary predicate devices. As such, we concluded that the substantial equivalence of the subject and the predicate devices has been met, and the differences between the subject and predicate do not raise new questions of safety and effectiveness.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
PINPOINT Endoscopic Fluorescence Imaging System (K182606), KARL STORZ ICG Imaging System (K201399)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 876.1500 Endoscope and accessories.
(a)
Identification. An endoscope and accessories is a device used to provide access, illumination, and allow observation or manipulation of body cavities, hollow organs, and canals. The device consists of various rigid or flexible instruments that are inserted into body spaces and may include an optical system for conveying an image to the user's eye and their accessories may assist in gaining access or increase the versatility and augment the capabilities of the devices. Examples of devices that are within this generic type of device include cleaning accessories for endoscopes, photographic accessories for endoscopes, nonpowered anoscopes, binolcular attachments for endoscopes, pocket battery boxes, flexible or rigid choledochoscopes, colonoscopes, diagnostic cystoscopes, cystourethroscopes, enteroscopes, esophagogastroduodenoscopes, rigid esophagoscopes, fiberoptic illuminators for endoscopes, incandescent endoscope lamps, biliary pancreatoscopes, proctoscopes, resectoscopes, nephroscopes, sigmoidoscopes, ureteroscopes, urethroscopes, endomagnetic retrievers, cytology brushes for endoscopes, and lubricating jelly for transurethral surgical instruments. This section does not apply to endoscopes that have specialized uses in other medical specialty areas and that are covered by classification regulations in other parts of the device classification regulations.(b)
Classification —(1)Class II (special controls). The device, when it is an endoscope disinfectant basin, which consists solely of a container that holds disinfectant and endoscopes and accessories; an endoscopic magnetic retriever intended for single use; sterile scissors for cystoscope intended for single use; a disposable, non-powered endoscopic grasping/cutting instrument intended for single use; a diagnostic incandescent light source; a fiberoptic photographic light source; a routine fiberoptic light source; an endoscopic sponge carrier; a xenon arc endoscope light source; an endoscope transformer; an LED light source; or a gastroenterology-urology endoscopic guidewire, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.(2) Class I for the photographic accessories for endoscope, miscellaneous bulb adapter for endoscope, binocular attachment for endoscope, eyepiece attachment for prescription lens, teaching attachment, inflation bulb, measuring device for panendoscope, photographic equipment for physiologic function monitor, special lens instrument for endoscope, smoke removal tube, rechargeable battery box, pocket battery box, bite block for endoscope, and cleaning brush for endoscope. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807of this chapter, subject to the limitations in § 876.9.
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food & Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which consists of the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG" in blue, with the word "ADMINISTRATION" underneath in a smaller font.
KARL STORZ Endoscopy America, Inc. Alita McElroy Regulatory Affairs Specialist 2151 E. Grand Avenue El Segundo, California 90245
December 17, 2020
Re: K202925
Trade/Device Name: KARL STORZ ICG Imaging System Regulation Number: 21 CFR 876.1500 Regulation Name: Endoscope and Accessories Regulatory Class: Class II Product Code: OWN, GWG Dated: September 28, 2020 Received: September 29, 2020
Dear Alita McElroy:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's
1
requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Neil R. P. Ogden Assistant Director DHT4A: Division of General Surgery Devices OHT4: Office of Surgical and Infection Control Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K202925
Device Name KARL STORZ ICG Imaging System
Indications for Use (Describe)
The KARL STORZ ICG Imaging System is intended to provide real-time visible (VIS) and near-infrared (NIR) fluorescence imaging.
Upon intravenous administration and use of ICG consistent with its approved label, the KARL STORZ Endoscopic ICG System enables surgeons to perform minimally invasive surgery using standard endoscopic visible light as well as visual assessment of vessels, blood flow and related tissue perfusion, and at least one of the major extra-hepatic bile ducts (cystic duct, common bile duct and common hepatic duct), using near infrared imaging of biliary ducts with the KARL STORZ Endoscopic ICG System is intended for use with standard of care white light and, when indicated, intraoperative cholangiography. The device is not intended for standalone use for biliary duct visualization.
Additionally, the KARL STORZ Endoscopic ICG System enables surgeon to perform minimally invasive cranial neurosurgery in adults and pediatrics and endonasal skull base surgery in adults and pediatrics > 6 years of age using standard endoscopic visible light as well as visual assessment of vessels, blood flow and related tissue perfusion using near infrared imaging.
The KARL STORZ VITOM II ICG System is intended for capturing fluorescent mages for the visual assessment of blood flow, as an adjunctive method for the evaluation of tissue perfusion, and related tissue-transfer circulation in tissue and free flaps used in plastic, micro- and reconstructive surgical procedures. The VITOM II ICG System is intended to provide a magnified view of the surgical field in standard white light.
Upon interstitial administration and use of ICG consistent with its approved label, the KARL STORZ Endoscopic ICG System is used to perform intraoperative fluorescence imaging and visualization of the lymphatic system, including lymphatic vessels and lymph nodes.
Type of Use (Select one or both, as applicable)
| ✖ Prescription Use (Part 21 CFR 801 Subpart D) | ❏ Over-The-Counter Use (21 CFR 801 Subpart C) |
|---|---|
| ------------------------------------------------------------------------------------ | ----------------------------------------------------------------------------------- |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/0 description: The image shows the logo for Karl Storz Endoskope. The logo is blue and features the word "STORZ" in large, bold letters. Below the word "STORZ" is the phrase "KARL STORZ - ENDOSKOPE" in smaller letters.
K202925 KARL STORZ Premarket Notification KARL STORZ ICG Imaging System 510(k) Summary
510(k) Summary
This 510(k) Summary is being submitted in accordance with the requirements of the Safe Medical Devices Act (SMDA) of 1990 and 21 CFR 807.92. All data included in this document is accurate and complete to the best of KSEA's knowledge.
| Submitter: | KARL STORZ Endoscopy-America, Inc.
2151 E. Grand Avenue
EI Segundo, CA 90245 |
|-----------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Contact: | Alita McElroy
Regulatory Affairs Specialist
Phone: (424) 218-8376
Fax: (424) 218-8519 |
| 510(k) Number: | K202925 |
| Date of
Preparation: | December 16, 2020 |
| Type of 510(k)
Submission: | Traditional |
| Trade Name: | KARL STORZ ICG Imaging System |
| Common Name: | Confocal Optical Imaging |
| Regulatory
Class: | II |
| Product Code: | OWN, GWG |
| Classification
Number and
Name: | 21 CFR 876.1500 (Endoscope and Accessories)
21 CFR 882.1480 (Neurological Endoscopes) |
| Predicate
Device(s): | PINPOINT Endoscopic Fluorescence Imaging System (K182606)-
Primary
KARL STORZ ICG Imaging System (K201399)- Secondary |
| Device
Description: | The subject device, KARL STORZ ICG Imaging System includes the
following components :
4mm, 5mm & 10mm HOPKINS ICG/NIR EndoscopesVITOM II ICG TelescopeImage1 S Rubina Camera headPower LED Rubina light source, footswitchFiber Light CablesImage1 S CCU |
| | The expanded indication for visualization of the lymphatic vessel is
only to the Endoscopic ICG system that includes the 4mm, 5mm &
10mm HOPKINS ICG/NIR Endoscopes.
The addition of the reprocessing modalities is to the 4mm, 5mm &
10mm HOPKINS ICG/NIR Endoscopes and the VITOM II ICG/NIR
telescope. |
| | The endoscopes/telescope are intended to be connected to the optical
coupler of the camera head, which connects to the CCU for image
processing, as well as to the light source via compatible light cable as
the source of illumination to allow visualization of internal anatomy.
The users can switch between WLi (standard white light) mode, for
visualization of the endoscopic and microscopic procedures and NIR
(Near Infrared) mode to detect ICG presence. |
| | The KARL STORZ ICG Imaging System can be used with any
medical grade monitor with a DVI-D or 12G/3G-SDI input. |
| Intended Use | The KARL STORZ ICG Imaging System is intended to provide real-
time visible and near-infrared fluorescence imaging. |
| Indications for
Use: | The KARL STORZ ICG Imaging System is intended to provide real-
time visible (VIS) and near-infrared (NIR) fluorescence imaging. |
| | Upon intravenous administration and use of ICG consistent with its
approved label, the KARL STORZ Endoscopic ICG System enables
surgeons to perform minimally invasive surgery using standard
endoscopic visible light as well as visual assessment of vessels, blood
flow and related tissue perfusion, and at least one of the major extra-
hepatic bile ducts (cystic duct, common bile duct and common hepatic
duct), using near infrared imaging. Fluorescence imaging of biliary
ducts with the KARL STORZ Endoscopic ICG System is intended for
use with standard of care white light and, when indicated,
intraoperative cholangiography. The device is not intended for
standalone use for biliary duct visualization. |
| | Additionally, the KARL STORZ Endoscopic ICG System enables
surgeon to perform minimally invasive cranial neurosurgery in adults
and pediatrics and endonasal skull base surgery in adults and
pediatrics > 6 years of age using standard endoscopic visible light as
well as visual assessment of vessels, blood flow and related tissue
perfusion using near infrared imaging. |
| Comparison of
Indication for
Use: | and viewing fluorescent images for the visual assessment of blood
flow, as an adjunctive method for the evaluation of tissue perfusion,
and related tissue-transfer circulation in tissue and free flaps used in
plastic, micro- and reconstructive surgical procedures. The VITOM IIfield in standard white light.
Upon interstitial administration and use of ICG consistent with its approved label, the KARL STORZ Endoscopic ICG System is used to perform intraoperative fluorescence imaging and visualization of the lymphatic system, including lymphatic vessels and lymph nodes. |
| | The subject device includes the endoscopic system (4mm, 5mm &
10mm HOPKINS ICG/NIR Endoscopes) for fluorescence imaging and
visualization of the lymphatic system in addition to the already cleared
minimally invasive procedures, neurosurgery, endonasal skull base
surgery.
The primary predicate device only includes the endoscopic system for
fluorescence imaging and visualization of the lymphatic system and
for minimally invasive procedures. The difference in the indication
does not raise new issues of safety and effectiveness because the
primary predicate device is chosen to only support the expanded
indication of the subject device i.e imaging and visualization of the
lymphatic system as the other indications of the subject device have
been previously cleared. |
| | The subject device includes imaging and visualization of the lymphatic
system in addition to the already cleared minimally invasive
procedures, neurosurgery, endonasal skull base surgery, whereas the
secondary predicate device is only indicated for minimally invasive
surgery, neurosurgery and endonasal skull base surgery. The
difference in indication does not raise new issues of safety and
effectiveness because the secondary predicate is chosen due to its identical intended use, operating principles and technological characteristics. |
| Technological
Characteristics: | The KARL STORZ ICG Imaging System is substantially equivalent to
the legally marketed primary predicate device, PINPOINT Endoscopic
Fluorescence Imaging System cleared under K182606 and the
secondary predicate device, KARL STORZ ICG Imaging System
cleared under K201399.
The primary predicate was chosen to support the expanded indication
for imaging and visualization of the lymphatic system. The subject and
primary predicate device are identical in terms of intended use and
mode of imaging to provide real time visible (VIS) and near-infrared
fluorescence (NIR) imaging. The subject and primary predicate
devices have the same integral components – a light source and light
cable for outputting light, a camera control unit for processing NIR
and VIS light images, a camera head and rigid endoscopes for VIS and
NIR light illumination and imaging. The main differences between the
subject primary predicate devices include the following:
The subject device can output a 4K image to the monitor while
the primary predicate device outputs a high definition image. The subject device uses a LED light source for NIR imaging
whereas the predicate device provides NIR light using laser
diode. In NIR mode, the subject device displays either one of the
three ICG presentations whereas the primary predicate device
generates a parallel display showing four simultaneous images
on the monitor. The subject and secondary devices have identical intended use,
operating principles, technological characteristics. The differences
between the subject device and the cleared KARL STORZ ICG
Imaging System are the expanded indication for use of the ICG
Endoscopic System (4mm, 5mm & 10mm HOPKINS ICG/NIR
endoscopes) for imaging and visualization of the lymphatic system and
the addition of sterilization modalities to the ICG scopes (4mm, 5mm,
10mm HOPKINS ICG/NIR Endoscopes and VITOM II ICG/NIR
telescope). |
| Non-Clinical
Performance
Data: | There are no performance standards or special controls developed
under Section 514 of the FD&C Act for endoscopes.
However, the KARL STORZ ICG Imaging System follows the FDA
recognized consensus standards and is tested according to the
following standards and FDA Guidance: Electrical Safety and EMC |
| | |
| | o IEC 60601-1
o IEC 60601-1-2
o IEC 60601-2-18
• ISO Endoscopic Standards
o ISO 8600-1
o ISO 8600-3
o ISO 8600-4
o ISO 8600-5
o ISO 8600-6 |
| | The expansion of the indication of the subject device does not change
the biocompatibility, electrical safety, electromagnetic compatibility,
or software validations and remain identical since last clearance
(K201399). |
| | Sterilization validations of the additional modalities were conducted
for the HOPKINS ICG/NIR Endoscopes and the VITOM II ICG/NIR
telescopes. |
| | The performance of the subject device, KARL STORZ ICG Imaging
System for VIS imaging has been verified and previously cleared in
K201399 as the expanded indication for fluorescence imaging and
visualization of the lymphatic system does not affect its performance
in white light mode.
The photobiological safety of the subject device per the FDA
recognized standard IEC 62471 has been verified and previously
cleared in K201399. |
| | The performance of the subject device for NIR imaging has been
demonstrated by comparing to the primary predicate device,
PINPOINT Endoscopic Fluorescence Imaging System to support the
expanded indication for fluorescent imaging and visualization of the
lymphatic system |
| Clinical
Performance
Data: | Clinical testing was not required to demonstrate the substantial
equivalence to the predicate devices. Non-clinical bench testing was
sufficient to establish substantial equivalence of the expanded
indications. |
| Conclusion: | The conclusions drawn from the cleaning and sterilization data
(Section 17), Software Data (Section 19), Electrical Safety and EMC
data (Section 20), as well as the Bench Top Performance Data (Section
21) demonstrated that the subject device is as safe and as effective as |
4
Image /page/4/Picture/0 description: The image shows the logo for Karl Storz Endoskope. The logo is in blue and features the word "STORZ" in large, bold letters. Below the word "STORZ" is the phrase "KARL STORZ - ENDOSKOPE" in smaller letters.
5
Image /page/5/Picture/0 description: The image shows the logo for Karl Storz Endoskope. The logo is in blue and features the word "STORZ" in large, bold letters. Below the word "STORZ" is the phrase "KARL STORZ - ENDOSKOPE" in smaller letters.
6
Image /page/6/Picture/0 description: The image contains the logo for Karl Storz Endoskope. The word "STORZ" is in large, bold, blue letters. Below that, in smaller blue letters, is the phrase "KARL STORZ - ENDOSKOPE".
K202925 KARL STORZ Premarket Notification KARL STORZ ICG Imaging System 510(k) Summary
7
Image /page/7/Picture/0 description: The image shows the logo for Karl Storz Endoskope. The word "STORZ" is in large, bold, blue letters. Below that, the words "KARL STORZ - ENDOSKOPE" are in smaller, blue letters. The logo is simple and professional.
8
Image /page/8/Picture/0 description: The image is a logo for Karl Storz Endoskope. The word "STORZ" is in large, bold, blue letters. Below that, the words "KARL STORZ - ENDOSKOPE" are in smaller, blue letters.
K202925 KARL STORZ Premarket Notification KARL STORZ ICG Imaging System 510(k) Summary
the primary and secondary predicate devices. As such, we concluded that the substantial equivalence of the subject and the predicate devices has been met, and the differences between the subject and predicate do not raise new questions of safety and effectiveness.